Search

everythinglearnresearchcommunity

for

Search:↓

A man developed neurological issues from SARS-CoV-2 without severe breathing problems, worsening to death.

Rosella C. believes an earlier diagnosis of Cushing disease could have prevented severe symptoms.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

The pandemic changed how often certain skin conditions were diagnosed.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Lyophilized platelet-rich plasma is beneficial and effective for various medical treatments, including tissue regeneration and hair regrowth.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.